Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Endo International plc | d930606d8k.htm |
| EX-23.1 - EX-23.1 - Endo International plc | d930606dex231.htm |
| EX-99.2 - EX-99.2 - Endo International plc | d930606dex992.htm |
| EX-23.4 - EX-23.4 - Endo International plc | d930606dex234.htm |
| EX-23.3 - EX-23.3 - Endo International plc | d930606dex233.htm |
| EX-99.4 - EX-99.4 - Endo International plc | d930606dex994.htm |
| EX-99.3 - EX-99.3 - Endo International plc | d930606dex993.htm |
| EX-99.1 - EX-99.1 - Endo International plc | d930606dex991.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement No. 333-194253 on Form S-8 of Endo International plc of our report dated March 12, 2015 with respect to the consolidated financial statements of Par Pharmaceutical Holdings, Inc. included in this Current Report on Form 8-K.
/s/ Ernst & Young LLP
MetroPark, New Jersey
June 2, 2015